Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 12 studies | 32% ± 10% | |
retinal rod cell | 8 studies | 36% ± 14% | |
endothelial cell | 5 studies | 21% ± 3% | |
astrocyte | 5 studies | 29% ± 7% | |
glutamatergic neuron | 4 studies | 49% ± 21% | |
retinal bipolar neuron | 4 studies | 26% ± 5% | |
Mueller cell | 4 studies | 35% ± 9% | |
endothelial cell of lymphatic vessel | 4 studies | 21% ± 3% | |
GABAergic neuron | 4 studies | 42% ± 18% | |
rod bipolar cell | 3 studies | 22% ± 5% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 7% | |
interneuron | 3 studies | 36% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2068.43 | 2641 / 2642 | 99% | 13.46 | 701 / 705 |
adrenal gland | 100% | 2428.50 | 258 / 258 | 98% | 13.37 | 226 / 230 |
kidney | 97% | 862.01 | 86 / 89 | 93% | 8.62 | 838 / 901 |
prostate | 93% | 780.42 | 227 / 245 | 93% | 7.33 | 467 / 502 |
thymus | 97% | 826.90 | 636 / 653 | 86% | 4.44 | 518 / 605 |
breast | 90% | 695.51 | 415 / 459 | 86% | 4.96 | 958 / 1118 |
lung | 99% | 1243.31 | 571 / 578 | 56% | 2.47 | 651 / 1155 |
liver | 57% | 300.07 | 129 / 226 | 89% | 8.56 | 363 / 406 |
skin | 51% | 252.14 | 930 / 1809 | 91% | 10.49 | 429 / 472 |
uterus | 96% | 850.69 | 163 / 170 | 46% | 2.51 | 209 / 459 |
pancreas | 50% | 233.82 | 163 / 328 | 76% | 3.58 | 136 / 178 |
intestine | 87% | 780.41 | 844 / 966 | 37% | 1.60 | 195 / 527 |
bladder | 86% | 662.29 | 18 / 21 | 33% | 1.52 | 168 / 504 |
esophagus | 71% | 664.44 | 1020 / 1445 | 42% | 2.01 | 76 / 183 |
muscle | 100% | 4051.22 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1640.96 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1044.03 | 1318 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1521.29 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 14.27 | 78 / 80 |
stomach | 44% | 372.47 | 158 / 359 | 50% | 2.57 | 142 / 286 |
lymph node | 0% | 0 | 0 / 0 | 93% | 5.76 | 27 / 29 |
adipose | 87% | 700.75 | 1050 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 67% | 4.28 | 30 / 45 |
ovary | 37% | 168.52 | 66 / 180 | 17% | 0.54 | 74 / 430 |
peripheral blood | 19% | 138.33 | 172 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0036151 | Biological process | phosphatidylcholine acyl-chain remodeling |
GO_0006954 | Biological process | inflammatory response |
GO_0006663 | Biological process | platelet activating factor biosynthetic process |
GO_0140042 | Biological process | lipid droplet formation |
GO_0036152 | Biological process | phosphatidylethanolamine acyl-chain remodeling |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0046475 | Biological process | glycerophospholipid catabolic process |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0007567 | Biological process | parturition |
GO_0005886 | Cellular component | plasma membrane |
GO_0005811 | Cellular component | lipid droplet |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0008970 | Molecular function | phospholipase A1 activity |
GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
GO_0008374 | Molecular function | O-acyltransferase activity |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0047499 | Molecular function | calcium-independent phospholipase A2 activity |
GO_0004622 | Molecular function | lysophospholipase activity |
GO_0102545 | Molecular function | phosphatidyl phospholipase B activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PLA2G4C |
Protein name | Phospholipase A2, group IVC(Cytosolic, calcium-independent) PLA2G4C protein Phospholipase A2 group IVC Cytosolic phospholipase A2 gamma (cPLA2-gamma) (EC 3.1.1.4) (Cytosolic lysophospholipase) (EC 3.1.1.5) (Cytosolic lysophospholipid O-acyltransferase) (EC 2.3.1.-) (Phospholipase A2 group IVC) |
Synonyms | |
Description | FUNCTION: Calcium-independent phospholipase, lysophospholipase and O-acyltransferase involved in phospholipid remodeling with implications in endoplasmic reticulum membrane homeostasis and lipid droplet biogenesis . Preferentially hydrolyzes the ester bond of the fatty acyl group attached at the sn-2 position of phospholipids with choline and ethanolamine head groups, producing lysophospholipids that are used in deacylation-reacylation cycles . Transfers the sn-1 fatty acyl from one lysophospholipid molecule to the sn-2 position of another lysophospholipid to form diacyl, alkylacyl and alkenylacyl glycerophospholipids. Cleaves ester bonds but not alkyl or alkenyl ether bonds at sn-1 position of lysophospholipids . Catalyzes sn-2 fatty acyl transfer from phospholipids to the sn-2 position of 1-O-alkyl or 1-O-alkenyl lysophospholipids with lower efficiency . In response to dietary fatty acids, may play a role in the formation of nascent lipid droplets from the endoplasmic reticulum likely by regulating the phospholipid composition of these organelles . .; FUNCTION: (Microbial infection) May play a role in replication and assembly of human hepatitis C virus (HCV) . In response to HCV infection, promotes remodeling of host endoplasmic reticulum membranes to form organelle-like structures called membranous web, where HCV replication occur . Can further mediate translocation of replication complexes to lipid droplets to enable virion assembly . .; FUNCTION: (Microbial infection) May facilitate human T-lymphotropic virus type 1 (HTLV-1) infection by promoting leukotriene B4 (LTB4) biosynthesis. LTB4 acts as a chemoattractant for HTLV-1-infected CD4-positive T cells and favors cell to cell viral transmission. . |
Accessions | ENST00000595161.5 M0R339 ENST00000599921.6 [Q9UP65-1] M0R0M8 M0QX83 ENST00000599111.5 [Q9UP65-3] Q8WWC5 ENST00000596138.1 ENST00000597713.1 Q76EZ0 Q9UP65 M0R0F6 M0QZB1 ENST00000596352.5 M0QY18 M0R1B4 ENST00000601946.1 ENST00000595487.5 M0R3I9 ENST00000354276.7 [Q9UP65-2] ENST00000598488.1 ENST00000599300.5 Q76EY9 |